SecBot SecBot
SECBOTREPLAY Home › Report › TNGX

TNGX · Tango Therapeutics formalized the separation of former CFO Daniella…

Tango Therapeutics, Inc. · 8-K filed May 8, 2026 at 09:22 ET

At the news

NEUTRALIMPACT 2/10

8-K filed May 8, 2026 at 09:22 ET

Tango Therapeutics formalized the separation of former CFO Daniella Beckman, who was terminated without cause effective May 1, 2026. The separation agreement provides 12 months of base salary severance, COBRA premium reimbursement for up to 12 months, accelerated vesting of equity that would have vested over the next 24 months, and an extended stock option exercise period through August 31, 2026. This is a routine administrative filing formalizing a previously announced CFO departure with standard severance terms, no new material financial information or strategic implications.

  • CFO Daniella Beckman's employment terminated without cause effective May 1, 2026; separation agreement signed May 7, 2026
  • Severance includes 12 months of base salary paid in installments and COBRA premium reimbursement for up to 12 months
  • Equity acceleration: unvested time-based options and RSUs that would have vested over 24 months post-termination will accelerate and vest as of termination date
  • Stock option exercise period extended through August 31, 2026 for vested options

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access